TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
RGC

Regencell Bioscience Holdings Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

6.30$ +1.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow RGC
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
11.4% 11.7% 13.9% 12.8% 13.0% – – – – – – –
6.7% 7.1% 6.9% 7.2% 8.1% – – – – – – –
0.3% 0.3% 0.3% 0.3% 0.3% – – – – – – –
0.0% -1.4% 1.1% -2.1% -1.1% – – – – – – –
3.7% 5.2% 5.9% 6.7% 7.9% – – – – – – –
4.4% 9.9% 4.4% 4.3% 4.4% – – – – – – –
-9.2% -4.9% – – -7.2% – – – – – – –
2.7% -11.1% -5.7% -5.0% -0.5% – – – – – – –
5.7% -4.4% 2.3% 0.8% -0.6% – – – – – – –
7.7% 6.4% 8.0% 6.1% 5.0% – – – – – – –

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?